Areño, Edna L.

HRN: 22-48-70  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/20/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
03/20/2023
03/26/2023
IV
600mg
Q8
SSI
Waiting Final Action 
03/20/2023
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
03/20/2023
03/26/2023
IV
750mg
Q24
SSI
Waiting Final Action 
03/21/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/21/2023
03/28/2023
IV
225 Mg
Q8H
T/c Sepsis
Waiting Final Action 
03/23/2023
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
03/23/2023
03/30/2023
IV
500mg
OD
Surgical Site Infection
Waiting Final Action 
03/23/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/23/2023
03/30/2023
IV
225mg
Q12HRS
Surgical Site Infection
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: